ACE-Hemmer bei kardialen Hochrisikopatienten Primäranalyse der HOPE-Studie View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-03

AUTHORS

B. Schieffer, H. Drexler, W. Lehmacher

ABSTRACT

(sn) Bei Patienten mit linksventrikulärer Dysfunktion sind ACE-Hemmer, unabhängig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskulärer Ereignisse nicht nur bei herzinsuffizienten Patienten erhöht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der präventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikuläre Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie. More... »

PAGES

431-434

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2

DOI

http://dx.doi.org/10.1007/s00108-002-0548-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036671496

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11963727


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin-Converting Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ramipril", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Dysfunction, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medizinische Hochschule Hannover, DE", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Medizinische Hochschule Hannover, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schieffer", 
        "givenName": "B.", 
        "id": "sg:person.01075113266.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075113266.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medizinische Hochschule Hannover, DE", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Medizinische Hochschule Hannover, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Drexler", 
        "givenName": "H.", 
        "id": "sg:person.010063330502.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010063330502.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Medizinische Statistik, Informatik und Epidemiologie, K\u00f6ln, DE", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institut f\u00fcr Medizinische Statistik, Informatik und Epidemiologie, K\u00f6ln, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmacher", 
        "givenName": "W.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-03", 
    "datePublishedReg": "2002-03-01", 
    "description": "Abstract(sn) Bei Patienten mit linksventrikul\u00e4rer Dysfunktion sind ACE-Hemmer, unabh\u00e4ngig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskul\u00e4rer Ereignisse nicht nur bei herzinsuffizienten Patienten erh\u00f6ht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der pr\u00e4ventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikul\u00e4re Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00108-002-0548-2", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1399751", 
        "issn": [
          "0020-9554", 
          "1432-1289"
        ], 
        "name": "Der Internist", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "43"
      }
    ], 
    "keywords": [
      "Renin-Angiotensin", 
      "bei", 
      "DAS", 
      "DERs", 
      "Ziel", 
      "Wahl", 
      "war"
    ], 
    "name": "ACE-Hemmer bei kardialen Hochrisikopatienten Prim\u00e4ranalyse der HOPE-Studie", 
    "pagination": "431-434", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036671496"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00108-002-0548-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11963727"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00108-002-0548-2", 
      "https://app.dimensions.ai/details/publication/pub.1036671496"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_349.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00108-002-0548-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'


 

This table displays all metadata directly associated to this object as RDF triples.

128 TRIPLES      20 PREDICATES      44 URIs      36 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00108-002-0548-2 schema:about N06960eea6a6b44e983fc431017f9b4aa
2 N0f2c710ff56d469f96fd74931bf41553
3 N57de0f4a3c254a92abbabe27cfe4e9b5
4 N5e8b483cc7944165b76723405482a0ab
5 N65cba3a72fc4460c9755adf29af20688
6 N65f87759ba2a4b74b87a41370ba43c5d
7 N7150d6e192f345ed8f852344dc1a9072
8 N9604b76941bd479e9c320c4cfbe0e14e
9 Nb4718775fe8a4f2aab8b754e5da2600f
10 Nef0deafe8e8c4ccc9ba97fea1c6ec628
11 Nfbb56893174b4cc889c8c3c63531e303
12 anzsrc-for:11
13 anzsrc-for:1116
14 schema:author N7b6ef992e9644afa8eca886f42cd2bcd
15 schema:datePublished 2002-03
16 schema:datePublishedReg 2002-03-01
17 schema:description Abstract(sn) Bei Patienten mit linksventrikulärer Dysfunktion sind ACE-Hemmer, unabhängig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskulärer Ereignisse nicht nur bei herzinsuffizienten Patienten erhöht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der präventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikuläre Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N18037ed495034f0bad28f6583da585b1
21 Ne9d649a36efa44ca9e09e629682a199f
22 sg:journal.1399751
23 schema:keywords DAS
24 DERs
25 Renin-Angiotensin
26 Wahl
27 Ziel
28 bei
29 war
30 schema:name ACE-Hemmer bei kardialen Hochrisikopatienten Primäranalyse der HOPE-Studie
31 schema:pagination 431-434
32 schema:productId N17180596b6e740888e3610c45826377f
33 N9633b69b4f734f8ab86fb1afea4653bb
34 N99a808aa8054414492f9677038d1fe18
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036671496
36 https://doi.org/10.1007/s00108-002-0548-2
37 schema:sdDatePublished 2022-09-02T15:49
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N0740320772de4253bbc99362b4de5901
40 schema:url https://doi.org/10.1007/s00108-002-0548-2
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N06960eea6a6b44e983fc431017f9b4aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Double-Blind Method
46 rdf:type schema:DefinedTerm
47 N0740320772de4253bbc99362b4de5901 schema:name Springer Nature - SN SciGraph project
48 rdf:type schema:Organization
49 N0f2c710ff56d469f96fd74931bf41553 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Angiotensin-Converting Enzyme Inhibitors
51 rdf:type schema:DefinedTerm
52 N17180596b6e740888e3610c45826377f schema:name doi
53 schema:value 10.1007/s00108-002-0548-2
54 rdf:type schema:PropertyValue
55 N18037ed495034f0bad28f6583da585b1 schema:volumeNumber 43
56 rdf:type schema:PublicationVolume
57 N313e3d4a41954c699899373d10ea9128 rdf:first sg:person.010063330502.67
58 rdf:rest N6cdbebf15e99455d914c9949f58be28e
59 N57de0f4a3c254a92abbabe27cfe4e9b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Humans
61 rdf:type schema:DefinedTerm
62 N5e8b483cc7944165b76723405482a0ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Dose-Response Relationship, Drug
64 rdf:type schema:DefinedTerm
65 N621df96b134243bfb71217127c3c137a schema:affiliation grid-institutes:None
66 schema:familyName Lehmacher
67 schema:givenName W.
68 rdf:type schema:Person
69 N65cba3a72fc4460c9755adf29af20688 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Survival Rate
71 rdf:type schema:DefinedTerm
72 N65f87759ba2a4b74b87a41370ba43c5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Ventricular Dysfunction, Left
74 rdf:type schema:DefinedTerm
75 N6cdbebf15e99455d914c9949f58be28e rdf:first N621df96b134243bfb71217127c3c137a
76 rdf:rest rdf:nil
77 N7150d6e192f345ed8f852344dc1a9072 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Female
79 rdf:type schema:DefinedTerm
80 N7b6ef992e9644afa8eca886f42cd2bcd rdf:first sg:person.01075113266.30
81 rdf:rest N313e3d4a41954c699899373d10ea9128
82 N9604b76941bd479e9c320c4cfbe0e14e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Ramipril
84 rdf:type schema:DefinedTerm
85 N9633b69b4f734f8ab86fb1afea4653bb schema:name pubmed_id
86 schema:value 11963727
87 rdf:type schema:PropertyValue
88 N99a808aa8054414492f9677038d1fe18 schema:name dimensions_id
89 schema:value pub.1036671496
90 rdf:type schema:PropertyValue
91 Nb4718775fe8a4f2aab8b754e5da2600f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Male
93 rdf:type schema:DefinedTerm
94 Ne9d649a36efa44ca9e09e629682a199f schema:issueNumber 3
95 rdf:type schema:PublicationIssue
96 Nef0deafe8e8c4ccc9ba97fea1c6ec628 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Aged
98 rdf:type schema:DefinedTerm
99 Nfbb56893174b4cc889c8c3c63531e303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Middle Aged
101 rdf:type schema:DefinedTerm
102 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
103 schema:name Medical and Health Sciences
104 rdf:type schema:DefinedTerm
105 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical Physiology
107 rdf:type schema:DefinedTerm
108 sg:journal.1399751 schema:issn 0020-9554
109 1432-1289
110 schema:name Der Internist
111 schema:publisher Springer Nature
112 rdf:type schema:Periodical
113 sg:person.010063330502.67 schema:affiliation grid-institutes:grid.10423.34
114 schema:familyName Drexler
115 schema:givenName H.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010063330502.67
117 rdf:type schema:Person
118 sg:person.01075113266.30 schema:affiliation grid-institutes:grid.10423.34
119 schema:familyName Schieffer
120 schema:givenName B.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075113266.30
122 rdf:type schema:Person
123 grid-institutes:None schema:alternateName Institut für Medizinische Statistik, Informatik und Epidemiologie, Köln, DE
124 schema:name Institut für Medizinische Statistik, Informatik und Epidemiologie, Köln, DE
125 rdf:type schema:Organization
126 grid-institutes:grid.10423.34 schema:alternateName Medizinische Hochschule Hannover, DE
127 schema:name Medizinische Hochschule Hannover, DE
128 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...